Share Price | Rezolute, Inc. Stock Analysis & Recommendation

Q: How big is Rezolute, Inc.?

As of Jun 18, Rezolute, Inc. has a market capitalization of 353.19 million, categorizing it as a Micro Cap company.As of Jun 24, the company reported net sales of 0.00 million for the latest four quarters, while the consolidated net profit for the same period was -73.00 million.As of Jun 24, the balance sheet shows shareholder's funds of 121.00 million and total assets of 132.74 million.

Q: What does Rezolute, Inc. do?

Overview:Rezolute, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.Financial Snapshot:Most recent Net Profit: -19 Million (Quarterly Results - Mar 2025) Market cap: USD 353.19 Million (Micro Cap)Key Metrics:P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -1.04 Return on Equity: -87.28% Price to Book: 4.28Contact Details:Registrar Address: Not available.

Q: Is Rezolute, Inc. technically bullish or bearish?

As of 24 July 2025, the technical trend for Rezolute, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both the weekly and monthly time frames, and Bollinger Bands also indicate bullishness across both periods. The daily moving averages are bullish, further reinforcing the positive trend. However, the KST shows a mildly bearish signal on the monthly, and Dow Theory indicates a mildly bullish stance on both weekly and monthly time frames.In terms of performance, Rezolute has significantly outperformed the S&P 500 across multiple periods, with a year-to-date return of 67.35% compared to the S&P 500's 12.22%, and a one-year return of 68.38% versus 17.14%. Overall, the technical indicators suggest a strong bullish sentiment for Rezolute, Inc.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.11 M

Shareholding (Sep 2025)

FII

11.21%

Held by 35 FIIs

DII

46.71%

Held by 49 DIIs

Promoter

2.58%

How big is Rezolute, Inc.?

22-Jun-2025

As of Jun 24, Rezolute, Inc. has a market capitalization of 353.19 million, with net sales of 0.00 million and a net profit of -73.00 million over the last four quarters. The company has shareholder's funds of 121.00 million and total assets of 132.74 million.

View full answer

What does Rezolute, Inc. do?

22-Jun-2025

Rezolute, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology sector, currently reporting a net profit loss of $19 million and a market cap of $353.19 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -87.28%.

View full answer

Is Rezolute, Inc. technically bullish or bearish?

20-Sep-2025

As of July 24, 2025, Rezolute, Inc. exhibits a strong bullish trend supported by positive MACD and Bollinger Bands indicators, despite a mildly bearish KST signal, and has significantly outperformed the S&P 500 with a year-to-date return of 67.35%.

View full answer

Compare Rezolute, Inc. with Similar Stocks

MEI Pharma, Inc.Minerva Neurosciences, Inc.SciSparc Ltd.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 263 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-1.03

Return on Equity

-52.45%

Price to Book

1.79

Revenue and Profits:

Net Sales:

(Quarterly Results - Mar 2025)

Net Profit:

-19 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-67.19%

6 Months

-50.51%

1 Year

-46.91%

2 Years

178.1%

3 Years

8.55%

4 Years

-33.79%

5 Years

-80.0%

Rezolute, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-212.93%

EBIT to Interest (avg)

-48.43

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.04

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

4.59

EV to EBIT

-3.79

EV to EBITDA

-3.79

EV to Capital Employed

-78.90

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-87.28%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bullish

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 23 Schemes (39.51%)

Foreign Institutions

Held by 35 Foreign Institutions (11.21%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is 0.00% vs 0.00% in Mar 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is -10.53% vs -8.92% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-20.00",
          "val2": "-16.20",
          "chgp": "-23.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "-2.00",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-18.90",
          "val2": "-17.10",
          "chgp": "-10.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jun'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jun 2024 is 0.00% vs 0.00% in Jun 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jun 2024 is -32.24% vs -26.03% in Jun 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'24",
        "Jun'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-70.40",
          "val2": "-55.60",
          "chgp": "-26.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.90",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-68.50",
          "val2": "-51.80",
          "chgp": "-32.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY

Mar'25

Mar'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-20.00

-16.20

-23.46%

Interest

0.00

Exceptional Items

-0.00

-2.00

100.00%

Consolidate Net Profit

-18.90

-17.10

-10.53%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2025 is 0.00% vs 0.00% in Mar 2024

Consolidated Net Profit

YoY Growth in quarter ended Mar 2025 is -10.53% vs -8.92% in Mar 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Jun'24

Jun'24

Jun'23

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-70.40

-55.60

-26.62%

Interest

0.00

Exceptional Items

-2.90

-0.00

Consolidate Net Profit

-68.50

-51.80

-32.24%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Jun 2024 is 0.00% vs 0.00% in Jun 2023

Consolidated Net Profit

YoY Growth in year ended Jun 2024 is -32.24% vs -26.03% in Jun 2023

All Annual Results

Company CV

About Rezolute, Inc.

Rezolute, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Rezolute, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Rezolute, Inc.?

Watch in Real-Time

What does Rezolute, Inc. do?

Is Rezolute, Inc. technically bullish or bearish?

Compare Rezolute, Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY

Annual Results Snapshot (Consolidated) - Jun'24

About Rezolute, Inc.

Company Coordinates